Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts.
http://www.fool.com/investing/general/2013/08/17/biotechs-falling-fortunes-stymie-osiriss-huge-week.aspx
http://www.fool.com/investing/general/2013/08/17/biotechs-falling-fortunes-stymie-osiriss-huge-week.aspx
No comments:
Post a Comment